Shanghai Haohai Biological Technology Co Ltd
SSE:688366

Watchlist Manager
Shanghai Haohai Biological Technology Co Ltd Logo
Shanghai Haohai Biological Technology Co Ltd
SSE:688366
Watchlist
Price: 61.2 CNY -1.66% Market Closed
Market Cap: 14.3B CNY
Have any thoughts about
Shanghai Haohai Biological Technology Co Ltd?
Write Note

Shanghai Haohai Biological Technology Co Ltd
Goodwill

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Shanghai Haohai Biological Technology Co Ltd
Goodwill Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Goodwill CAGR 3Y CAGR 5Y CAGR 10Y
Shanghai Haohai Biological Technology Co Ltd
SSE:688366
Goodwill
ÂĄ413m
CAGR 3-Years
2%
CAGR 5-Years
4%
CAGR 10-Years
N/A
Beigene Ltd
HKEX:6160
Goodwill
ÂĄ0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Innovent Biologics Inc
HKEX:1801
Goodwill
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
Goodwill
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
Goodwill
ÂĄ19.3m
CAGR 3-Years
0%
CAGR 5-Years
0%
CAGR 10-Years
0%
Imeik Technology Development Co Ltd
SZSE:300896
Goodwill
ÂĄ244.9m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Shanghai Haohai Biological Technology Co Ltd
Glance View

Market Cap
14.3B CNY
Industry
Biotechnology

Shanghai Haohai Biological Technology Co., Ltd. operates at the cutting edge of the biopharmaceutical industry, specializing in regenerative medicine, medical aesthetics, and other biotechnology applications. Founded on the principles of innovation and science-driven solutions, the company has built an impressive portfolio that underscores its expertise in biological materials. Core to its operations is the development and commercialization of hyaluronic acid products, pivotal in fields such as ophthalmology, wound care, and more recently, dermal fillers for aesthetic treatments. Haohai Biological leverages high-end biotechnological processes to produce its offerings, ensuring that they meet the highest standards of quality and efficacy—a strategy that has allowed it to capture significant market share both domestically within China and beyond its borders. The revenue streams of Haohai Biological are as diversified as its product lines. The company generates income primarily through the sale of its high-margin pharmaceutical and medical device products. It has strategically positioned itself in the burgeoning market for medical aesthetics, where demand for cosmetic enhancements is rapidly growing, fueled by a global shift toward non-invasive procedures. Additionally, its ophthalmic products, crucial for surgeries and various ocular conditions, continue to be significant revenue drivers. Beyond product sales, Haohai invests in licensing its technologies and forging strategic partnerships with international firms, further enhancing its market reach and capitalizing on global biotechnology trends. This multifaceted approach positions the company not only as a producer but as a leader in scientific innovation and commercialization in the biotechnology sector.

Intrinsic Value
81.96 CNY
Undervaluation 25%
Intrinsic Value
Price

See Also

What is Shanghai Haohai Biological Technology Co Ltd's Goodwill?
Goodwill
413m CNY

Based on the financial report for Dec 31, 2023, Shanghai Haohai Biological Technology Co Ltd's Goodwill amounts to 413m CNY.

What is Shanghai Haohai Biological Technology Co Ltd's Goodwill growth rate?
Goodwill CAGR 5Y
4%

Over the last year, the Goodwill growth was 0%. The average annual Goodwill growth rates for Shanghai Haohai Biological Technology Co Ltd have been 2% over the past three years , 4% over the past five years .

Back to Top